Skip to Content
You are currently on the new version of our website. Access the old version .

Most Cited

  • Review
  • Open Access
1,226 Citations
53,733 Views
17 Pages

Immune Checkpoint Inhibitors in Cancer Therapy

  • Yavar Shiravand,
  • Faezeh Khodadadi,
  • Seyyed Mohammad Amin Kashani,
  • Seyed Reza Hosseini-Fard and ,
  • Shadi Hosseini,
  • Habib Sadeghirad,
  • Rahul Ladwa,
  • Ken O’Byrne and
  • Arutha Kulasinghe
  • + 4 authors+ 0 author

24 April 2022

The discovery of immune checkpoint proteins such as PD-1/PDL-1 and CTLA-4 represents a significant breakthrough in the field of cancer immunotherapy. Therefore, humanized monoclonal antibodies, targeting these immune checkpoint proteins have been uti...

(This article belongs to the Special Issue Immune Checkpoint Inhibitors in Cancer Therapy: State of the Art and Future Perspectives)
  • Review
  • Open Access
873 Citations
32,964 Views
11 Pages

A Review of Cancer Immunotherapy: From the Past, to the Present, to the Future

  • K. Esfahani,
  • L. Roudaia,
  • N. Buhlaiga,
  • S.V. Del Rincon and ,
  • N. Papneja and
  • W.H. Miller
  • + 1 author+ 0 author

1 April 2020

Compared with previous standards of care (including chemotherapy, radiotherapy, and surgery), cancer immunotherapy has brought significant improvements for patients in terms of survival and quality of life. Immunotherapy has now firmly established it...

  • Article
  • Open Access
378 Citations
7,338 Views
8 Pages

1 February 2011

Objective: To review preclinical and clinical data for oxaliplatin in the current context of molecularly targeted therapy. Methods of Study Selection: We searched the PubMed and PubChem databases by combining the search terms “oxaliplatin” or “platin...

  • Article
  • Open Access
332 Citations
5,927 Views
19 Pages

Prophylaxis and Management of Acute Radiation-Induced Skin Reactions: A Systematic Review of the Literature

  • N. Salvo,
  • E. Barnes,
  • J. van Draanen,
  • E. Stacey and ,
  • G. Mitera,
  • D. Breen,
  • A. Giotis,
  • G. Czarnota,
  • J. Pang and
  • C. De Angelis
  • + 5 authors+ 0 author

1 August 2010

Radiation therapy is a common treatment for cancer patients. One of the most common side effects of radiation is acute skin reaction (radiation dermatitis) that ranges from a mild rash to severe ulceration. Approximately 85% of patients treated with...

  • Article
  • Open Access
267 Citations
18,791 Views
14 Pages

Classification of Brain Tumor from Magnetic Resonance Imaging Using Vision Transformers Ensembling

  • Sudhakar Tummala,
  • Seifedine Kadry,
  • Syed Ahmad Chan Bukhari and
  • Hafiz Tayyab Rauf

7 October 2022

The automated classification of brain tumors plays an important role in supporting radiologists in decision making. Recently, vision transformer (ViT)-based deep neural network architectures have gained attention in the computer vision research domai...

  • Review
  • Open Access
265 Citations
27,114 Views
12 Pages

9 March 2022

Lung cancer is the leading cause of cancer death in Canada and a significant cause of morbidity for patients and their loved ones. There have been rapid advances in preventing, screening and treating this disease. Here, we present a contemporary revi...

(This article belongs to the Special Issue 2021 Article Series of Canadian Association of General Practitioners in Oncology)
  • Review
  • Open Access
259 Citations
7,286 Views
9 Pages

Advances in the Systemic Treatment of Triple-Negative Breast Cancer

  • J.M. Lebert,
  • R. Lester,
  • E. Powell,
  • M. Seal and
  • J. McCarthy

1 June 2018

Triple-negative breast cancer constitutes a heterogeneous group of malignancies that are often aggressive and associated with a poor prognosis. Molecular characterization, while not a standard of care, can further subtype triple-negative breast cance...

  • Article
  • Open Access
251 Citations
7,507 Views
7 Pages

Exercise for People with Cancer: A Clinical Practice Guideline

  • R. Segal,
  • C. Zwaal,
  • E. Green,
  • J.R. Tomasone and ,
  • A. Loblaw,
  • T. Petrella and
  • the Exercise for People with Cancer Guideline Development Group
  • + 2 authors+ 0 author

1 February 2017

Background: Development of this guideline was undertaken by the Exercise for People with Cancer Guideline Development Group, a group organized by Cancer Care Ontario’s Program in Evidence-Based Care (pebc). The purpose of the guideline was to provide...

  • Article
  • Open Access
242 Citations
3,966 Views
11 Pages

Microrna Let-7: An Emerging Next-Generation Cancer Therapeutic

  • D. Barh,
  • R. Malhotra,
  • B. Ravi and
  • P. Sindhurani

1 February 2010

In recent years, various rna-based technologies have been under evaluation as potential next-generation cancer therapeutics. MicroRNAS (miRNAS), known to regulate the cell cycle and development, are deregulated in various cancers. Thus, they might se...

  • Review
  • Open Access
238 Citations
10,220 Views
10 Pages

1 October 2012

Objective: The aim of this systematic review and meta-analysis was to assess the effectiveness of mindfulness-based stress reduction (mbsr) and mindfulness-based cognitive therapy (mbct) in patients with breast cancer. Methods: The medline, Cochrane...

  • Review
  • Open Access
234 Citations
4,730 Views
12 Pages

1 January 2009

Background: Systematic symptom reporting by patients and the use of questionnaires such as the Edmonton Symptom Assessment System (ESAS) have potential to improve clinical encounters and patient satisfaction. We review findings from published studies...

  • Review
  • Open Access
231 Citations
19,027 Views
28 Pages

Pathological Features and Prognostication in Colorectal Cancer

  • Kabytto Chen,
  • Geoffrey Collins,
  • Henry Wang and
  • James Wei Tatt Toh

13 December 2021

The prognostication of colorectal cancer (CRC) has traditionally relied on staging as defined by the Union for International Cancer Control (UICC) and American Joint Committee on Cancer (AJCC) TNM staging classifications. However, clinically, there a...

(This article belongs to the Section Gastrointestinal Oncology)
  • Review
  • Open Access
227 Citations
15,889 Views
10 Pages

1 June 2018

Although screening mammography has delivered many benefits since its introduction in Canada in 1988, questions about perceived harms warrant an up-to-date review. To help oncologists and physicians provide optimal patient recommendations, the literat...

  • Review
  • Open Access
225 Citations
30,022 Views
27 Pages

Artificial Intelligence in Colorectal Cancer Screening, Diagnosis and Treatment. A New Era

  • Athanasia Mitsala,
  • Christos Tsalikidis,
  • Michail Pitiakoudis,
  • Constantinos Simopoulos and
  • Alexandra K. Tsaroucha

23 April 2021

The development of artificial intelligence (AI) algorithms has permeated the medical field with great success. The widespread use of AI technology in diagnosing and treating several types of cancer, especially colorectal cancer (CRC), is now attracti...

  • Review
  • Open Access
221 Citations
17,577 Views
14 Pages

Oral Squamous Cell Carcinoma and Concomitant Primary Tumors, What Do We Know? A Review of the Literature

  • Mohammed Badwelan,
  • Hasan Muaddi,
  • Abeer Ahmed,
  • Kyungjun T. Lee and
  • Simon D. Tran

27 March 2023

Head and neck cancer is among the top ten cancers worldwide, with most lesions in the oral cavity. Oral squamous cell carcinoma (OSCC) accounts for more than 90% of all oral malignancies and is a significant public health concern. Patients with OSCC...

(This article belongs to the Special Issue Advances in Squamous Cell Carcinoma of the Head and Neck)
  • Article
  • Open Access
215 Citations
5,702 Views
7 Pages

1 October 2007

Cancer patients often experience multiple symptoms, and those symptoms can independently predict changes in patient function, treatment failures, and post-therapeutic outcomes. Symptom clusters are defined as two or more concurrent symptoms that are...

  • Article
  • Open Access
215 Citations
6,573 Views
7 Pages

1 August 2013

Background: The prognosis of patients with brain metastases from non-small-cell lung cancer (NSCLC) is poor. However, some reports suggest that patients with brain metastases at the time of initial diagnosis have a more favourable survival than do pa...

  • Article
  • Open Access
208 Citations
4,301 Views
14 Pages

Optimal Chemotherapy Treatment for Women with Recurrent Ovarian Cancer

  • M. Fung-Kee-Fung,
  • T. Oliver,
  • L. Elit,
  • A. Oza and ,
  • H. W. Hirte,
  • P. Bryson and
  • on behalf of the Gynecology Cancer Disease Site Group of Cancer Care Ontario’s Program in Evidence-Based Care
  • + 2 authors+ 0 author

1 October 2007

Question: What is the optimal chemotherapy treatment for women with recurrent ovarian cancer who have previously received platinum-based chemotherapy? Perspectives: Currently, standard primary therapy for advanced disease involves a combination of ma...

  • Review
  • Open Access
205 Citations
45,190 Views
21 Pages

Cancer Pain Management: A Narrative Review of Current Concepts, Strategies, and Techniques

  • François Mestdagh,
  • Arnaud Steyaert and
  • Patricia Lavand’homme

18 July 2023

Pain is frequently reported during cancer disease, and it still remains poorly controlled in 40% of patients. Recent developments in oncology have helped to better control pain. Targeted treatments may cure cancer disease and significantly increase s...

(This article belongs to the Collection Editorial Board Members’ Collection Series: Contemporary Perioperative Concepts in Cancer Surgery)
  • Review
  • Open Access
203 Citations
23,792 Views
12 Pages

Synovial Sarcoma: A Clinical Review

  • Aaron M. Gazendam,
  • Snezana Popovic,
  • Sohaib Munir,
  • Naveen Parasu and ,
  • David Wilson and
  • Michelle Ghert
  • + 1 author+ 0 author

19 May 2021

Synovial sarcomas (SS) represent a unique subset of soft tissue sarcomas (STS) and account for 5–10% of all STS. Synovial sarcoma differs from other STS by the relatively young age at diagnosis and clinical presentation. Synovial sarcomas have unique...

(This article belongs to the Section Surgical Oncology)
  • Systematic Review
  • Open Access
202 Citations
18,233 Views
33 Pages

The Out-of-Pocket Cost Burden of Cancer Care—A Systematic Literature Review

  • Nicolas Iragorri,
  • Claire de Oliveira,
  • Natalie Fitzgerald and
  • Beverley Essue

15 March 2021

Background: Out-of-pocket costs pose a substantial economic burden to cancer patients and their families. The purpose of this study was to evaluate the literature on out-of-pocket costs of cancer care. Methods: A systematic literature review was cond...

  • Article
  • Open Access
191 Citations
3,826 Views
6 Pages

Gliadel Wafers in the Treatment of Malignant Glioma: A Systematic Review

  • James Perry,
  • A. Chambers,
  • K. Spithoff,
  • N. Laperriere and
  • on behalf of the Neuro-Oncology Disease Site Group§ of Cancer Care Ontario’s Program in Evidence-Based Care

1 October 2007

Question: What is the safety and efficacy of interstitial chemotherapy with carmustine-loaded polymers (Gliadel wafers: MGI Pharma, Bloomington, MN, U.S.A.) in the treatment of newly diagnosed or recurrent malignant glioma (that is, glioblastoma mult...

  • Review
  • Open Access
183 Citations
30,145 Views
9 Pages

Temozolomide (TMZ) in the Treatment of Glioblastoma Multiforme—A Literature Review and Clinical Outcomes

  • Marcin Jezierzański,
  • Natalia Nafalska,
  • Małgorzata Stopyra,
  • Tomasz Furgoł and ,
  • Michał Miciak,
  • Jacek Kabut and
  • Iwona Gisterek-Grocholska
  • + 2 authors+ 0 author

12 July 2024

Glioblastoma multiforme (GBM) is one of the most aggressive primary tumors of the central nervous system. It is associated with a very poor prognosis, with up to half of patients failing to survive the first year after diagnosis. It develops from gli...

(This article belongs to the Special Issue Treatment for Glioma: Retrospect and Prospect)
  • Review
  • Open Access
169 Citations
3,028 Views
1 Page

1 February 2006

An integrative approach for managing a patient with cancer should target the multiple biochemical and physiologic pathways that support tumour development and minimize normal-tissue toxicity. Angiogenesis is a key process in the promotion of cancer....

  • Article
  • Open Access
166 Citations
2,644 Views
9 Pages

Metronomic Chemotherapy: Changing the Paradigm That More Is Better

  • O. Graciela Scharovsky,
  • L. E. Mainetti and
  • V. R. Rozados

1 March 2009

The introduction of the “maximum tolerated dose” in usual treatment protocols (and its concomitant overt toxicity) made necessary the imposition of rest periods between cycles of therapy—a practice that not only involves re-growth of tumour cells, bu...

  • Article
  • Open Access
159 Citations
6,315 Views
9 Pages

Information Needs and Sources of Information for Patients during Cancer Follow-Up

  • M.A. Shea–Budgell,
  • X. Kostaras,
  • K.P. Myhill and
  • N.A. Hagen

1 August 2014

(1) Background: Now more than ever, cancer patients want health information. Little has been published to characterize the information needs and preferred sources of that information for patients who have completed cancer treatment. (2) Methods: We u...

  • Review
  • Open Access
157 Citations
17,898 Views
16 Pages

Immunotherapy in Gastric Cancer

  • Anica Högner and
  • Markus Moehler

2 March 2022

Immune checkpoint inhibition is a new standard of targeted therapy in the treatment of advanced or metastatic gastric cancer (GC) and is represented in various combinations with and without chemotherapy in every therapy line within clinical trials. I...

(This article belongs to the Special Issue In Search of More Effective and Less Invasive Ways to Treat Esophagus and Stomach Cancer)
  • Article
  • Open Access
153 Citations
5,991 Views
7 Pages

Complementary and Alternative Medicine Use in Patients Before and After a Cancer Diagnosis

  • C. A. Buckner,
  • R. M. Lafrenie,
  • J. A. Dénommée,
  • J. M. Caswell and
  • D. A. Want

1 August 2018

Background: Cancer patients are increasingly seeking out complementary and alternative medicine (CAM) and might be reluctant to disclose its use to their oncology treatment team. Often, CAM agents are not well studied, and little is known about their...

  • Article
  • Open Access
152 Citations
6,651 Views
6 Pages

1 May 2020

The Canadian Cancer Society estimated that 220,400 new cases of cancer would be diagnosed in 2019. Of the affected patients, more than 60% will survive for 5 years or longer after their cancer diagnosis. Furthermore, nearly 40% will receive at least...

  • Article
  • Open Access
145 Citations
2,691 Views
12 Pages

Cardiac Management during Adjuvant Trastuzumab Therapy: Recommendations of the Canadian Trastuzumab Working Group

  • J. R. Mackey,
  • M. Clemons,
  • M.A. Côté,
  • D. Delgado and ,
  • S. Dent,
  • A. Paterson,
  • L. Provencher,
  • M.B. Sawyer and
  • S. Verma
  • + 4 authors+ 0 author

1 January 2008

Trastuzumab has been shown to be an effective therapy for women with breast cancer that overexpresses the human epidermal growth factor receptor 2 (her2) protein. In the pivotal metastatic breast cancer trials, cardiac dysfunction was observed in wom...

  • Article
  • Open Access
145 Citations
6,964 Views
5 Pages

1 June 2019

Hematopoietic stem-cell transplantation (HSCT) is a medical procedure that consists of infusing stem cells after a short course of chemotherapy or radiotherapy, or both. It can be used in the treatment of various cancers, as well as some benign condi...

  • Review
  • Open Access
144 Citations
19,720 Views
22 Pages

Underlying Features of Prostate Cancer—Statistics, Risk Factors, and Emerging Methods for Its Diagnosis

  • Cristina V. Berenguer,
  • Ferdinando Pereira,
  • José S. Câmara and
  • Jorge A. M. Pereira

15 February 2023

Prostate cancer (PCa) is the most frequently occurring type of malignant tumor and a leading cause of oncological death in men. PCa is very heterogeneous in terms of grade, phenotypes, and genetics, displaying complex features. This tumor often has i...

(This article belongs to the Collection New Insights into Prostate Cancer Diagnosis and Treatment)
  • Article
  • Open Access
143 Citations
6,128 Views
8 Pages

Prevention and Management of Chemotherapy-Induced Diarrhea in Patients with Colorectal Cancer: A Consensus Statement by the Canadian Working Group on Chemotherapy-Induced Diarrhea

  • J. A. Maroun,
  • L. B. Anthony,
  • N. Blais,
  • R. Burkes and ,
  • S. D. Dowden,
  • G. Dranitsaris,
  • B. Samson,
  • A. Shah,
  • M. P. Thirlwell and
  • R. Wong
  • + 6 authors+ 1 author

1 February 2007

Chemotherapy-induced diarrhea (cid) is a common side effect of cancer treatment and can cause significant morbidity and mortality. Diarrhea is frequently severe enough to require a dose reduction of, a delay in, or a discontinuation of chemotherapy....

  • Article
  • Open Access
137 Citations
982 Views
7 Pages

The Predictive Value of Pre-treatment Inflammatory Markers in Advanced Non-small-Cell Lung Cancer

  • G. Kasymjanova,
  • N. MacDonald,
  • J. S. Agulnik,
  • V. Cohen and ,
  • C. Pepe,
  • H. Kreisman,
  • R. Sharma and
  • D. Small
  • + 3 authors+ 0 author

1 August 2010

Background: Accurate prediction of outcome in advanced non-small-cell lung cancer (NSCLC) remains challenging. Even within the same stage and treatment group, survival and response to treatment vary. We set out to determine the predictive value of in...

  • Article
  • Open Access
135 Citations
3,062 Views
12 Pages

Fine-Needle Sspiration Biopsy versus Core-Needle Biopsy in Diagnosing Lung Cancer: A Systematic Review

  • X. Yao,
  • M.M. Gomes,
  • M.S. Tsao,
  • C.J. Allen and ,
  • W. Geddie and
  • H. Sekhon
  • + 1 author+ 0 author

1 February 2012

Background: Lung cancer leads cancer-related mortality in the world. The objective of the present systematic review was to compare fine-needle aspiration biopsy (FNAB) with core-needle biopsy (CNB) for diagnostic characteristics and yields for diagno...

  • Review
  • Open Access
132 Citations
23,581 Views
26 Pages

Current Overview of Treatment for Metastatic Bone Disease

  • Shinji Tsukamoto,
  • Akira Kido,
  • Yasuhito Tanaka,
  • Giancarlo Facchini and ,
  • Giuliano Peta,
  • Giuseppe Rossi and
  • Andreas F. Mavrogenis
  • + 2 authors+ 0 author

29 August 2021

The number of patients with bone metastasis increases as medical management and surgery improve the overall survival of patients with cancer. Bone metastasis can cause skeletal complications, including bone pain, pathological fractures, spinal cord o...

(This article belongs to the Special Issue Treatment of Bone Metastasis)
  • Article
  • Open Access
130 Citations
5,302 Views
11 Pages

Use of Dexamethasone in Patients with High-Grade Glioma: A Clinical Practice Guideline

  • X. Kostaras,
  • F. Cusano,
  • G.A. Kline,
  • W. Roa and ,
  • J. Easaw and
  • CNS Tumour Team the Alberta Provincial
  • + 1 author+ 0 author

1 June 2014

Background: Dexamethasone is the corticosteroid most commonly used for the management of vasogenic edema and increased intracranial pressure in patients with brain tumours. It is also used after surgery (before embarking on radiotherapy), particularl...

  • Review
  • Open Access
130 Citations
5,235 Views
26 Pages

Exercise for People with Cancer: A Systematic Review

  • R. Segal,
  • C. Zwaal,
  • E. Green,
  • J.R. Tomasone and ,
  • A. Loblaw,
  • T. Petrella and
  • the Exercise for People with Cancer Guideline Development Group
  • + 2 authors+ 0 author

1 August 2017

Background: This systematic review was completed by the Exercise for People with Cancer Guideline Development Group, a group organized by Cancer Care Ontario’s Program in Evidence-Based Care (PEBC). It provides background and guidance for clinicians...

  • Article
  • Open Access
130 Citations
3,246 Views
12 Pages

Current Landscape of Immunotherapy in the Treatment of Solid Tumours, with Future Opportunities and Challenges

  • N. A. Nixon,
  • N. Blais,
  • S. Ernst,
  • C. Kollmannsberger and ,
  • G. Bebb,
  • M. Butler,
  • M. Smylie and
  • S. Verma
  • + 3 authors+ 0 author

1 October 2018

Immunotherapy has emerged as a new standard of care, showing survival benefit for solid tumours in multiple disease sites and indications. The survival improvements seen in diseases that were highly resistant to traditional therapies, with a poor pro...

  • Review
  • Open Access
128 Citations
20,213 Views
18 Pages

5 August 2021

Extramammary Paget’s disease (EMPD) is a rare neoplasm that usually develops in apocrine gland-bearing areas, such as the vulva, scrotum, and penis. EMPD may present with a focal, multifocal, or an ectopic lesion. Clinically, EMPD lesions often exhib...

  • Article
  • Open Access
128 Citations
3,563 Views
13 Pages

1 June 2011

Non-small-cell lung cancer (nsclc) has the highest prevalence of all types of lung cancer, which is the second most common cancer and the leading cause of cancer-related mortality in Canada. The need for more effective and less toxic treatment option...

  • Guidelines
  • Open Access
128 Citations
4,153 Views
14 Pages

Connecting People with Cancer to Physical Activity and Exercise Programs: A Pathway to Create Accessibility and Engagement

  • D. Santa Mina,
  • C.M. Sabiston,
  • D. Au,
  • A.J. Fong and ,
  • L.C. Capozzi,
  • D. Langelier,
  • M. Chasen,
  • J. Chiarotto,
  • J.R. Tomasone and
  • S.N. Culos-Reed
  • + 7 authors+ 2 authors

1 April 2018

Recent guidelines concerning exercise for people with cancer provide evidence-based direction for exercise assessment and prescription for clinicians and their patients. Although the guidelines promote exercise integration into clinical care for peop...

  • Article
  • Open Access
126 Citations
3,228 Views
11 Pages

Management of Skin Rash during egfr-Targeted Monoclonal Antibody Treatment for Gastrointestinal Malignancies: Canadian Recommendations

  • Barbara Melosky,
  • R. Burkes,
  • D. Rayson,
  • T. Alcindor and ,
  • N. Shear and
  • M. Lacouture
  • + 1 author+ 0 author

1 January 2009

The epidermal growth factor receptor (EGFR) is often overexpressed or dysregulated in a variety of solid tumours, including gastrointestinal (GI) malignancies. Agents targeting the EGFR-mediated signalling pathway are increasingly part of the therape...

  • Review
  • Open Access
124 Citations
1,874 Views
8 Pages

Two Cases of Acrometastasis to the Hands and Review of the Literature

  • C. J. Flynn,
  • C. Danjoux,
  • J. Wong,
  • M. Christakis and ,
  • J. Rubenstein,
  • A. Yee,
  • D. Yip and
  • E. Chow
  • + 3 authors+ 0 author

1 October 2008

This paper reports two cases of acrometastasis to the hands. The first case involved a 78-year-old woman with a permeative osteolytic lesion in her proximal second metacarpal. A biopsy of this lesion suggested a diagnosis of non-small-cell lung carci...

  • Review
  • Open Access
124 Citations
4,885 Views
10 Pages

1 June 2018

Endocrine therapy, a major modality in the treatment of hormone receptor (HR)–positive breast cancer (BCA), has improved outcomes in metastatic and nonmetastatic disease. However, a limiting factor to the use of endocrine therapy in BCA is resistance...

  • Article
  • Open Access
123 Citations
3,537 Views
14 Pages

A Pan-Canadian Practice Guideline and Algorithm: Screening, Assessment, and Supportive Care of Adults with Cancer-Related Fatigue

  • D. Howell,
  • S. Keller–Olaman,
  • T.K. Oliver,
  • T.F. Hack and ,
  • L. Broadfield,
  • K. Biggs,
  • J. Chung,
  • D. Gravelle,
  • E. Green and
  • K. Olson
  • + 11 authors+ 6 authors

1 June 2013

Purpose: The purpose of the present systematic review was to develop a practice guideline to inform health care providers about screening, assessment, and effective management of cancer-related fatigue (CRF) in adults. Methods: The internationally en...

XFacebookLinkedIn
Curr. Oncol. - ISSN 1718-7729